Vision Loss News and Research

RSS

Natalizumab (Tysabri) reduces vision loss in MS patients

According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI), a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS), also reduces vision loss in patients with relapsing MS.

17 Apr 2007

Natalizumab helps reduce vision loss

A drug that slows disability and reduces relapse rates in multiple sclerosis (MS) has been found to also reduce vision loss in patients with relapsing MS. Vision loss is one of the most common and debilitating symptoms of MS.

17 Apr 2007

Clinical trial of Ranibizumab for edema of the mAcula in diabetes

The Juvenile Diabetes Research Foundation, the world's largest charitable funder of type 1 diabetes research, announced that the Ranibizumab for Edema of the mAcula in Diabetes Phase 2 Study (READ 2) is now enrolling patients.

2 Apr 2007

Regular exercise protects against age related macular degeneration

AMD is a condition which causes light sensitive cells at the back of the eye to stop working, resulting in severe vision loss; it affects the central vision, needed for driving and for many other activities.

1 Nov 2006

New study to evaluate whether nutrient-based factors slow the progression of age-related macular degeneration

UT Southwestern Medical Center is participating in a nationwide study investigating whether modified combinations of vitamins, minerals and fish oil products can slow the progression of vision loss from age-related macular degeneration.

24 Oct 2006

Scientists identify gene called HTRA1 that contributes to a major risk of Age Related Macular Degeneration

Researchers at the John A. Moran Eye Center at the University of Utah have identified a gene called HTRA1 that contributes to a major risk of Age Related Macular Degeneration (AMD), the most common cause of irreversible vision loss in the developed world.

20 Oct 2006

New drug a breakthrough in the treatment of AMD

Age-related macular degeneration (AMD), is a common cause of vision loss and often affects older people.

5 Oct 2006

Innovative approach for creating a cytomegalovirus vaccine

Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus - almost one an hour.

2 Aug 2006

Scientists slow vision loss with vitamin E, alpha-lipoic acid and other antioxidant chemicals

Scientists at Johns Hopkins have successfully blocked the advance of retinal degeneration in mice with a form of retinitis pigmentosa (RP) by treating them with vitamin E, alpha-lipoic acid and other antioxidant chemicals.

24 Jul 2006

Antioxidants may slow vision loss

21 Jul 2006

New drug restores sight in sufferers from AMD

A new drug with the capacity to reverse vision loss in some patients with age-related macular degeneration (AMD) has won approval from the Food and Drug Administration (FDA) in the U.S.

3 Jul 2006

New drug helps diabetics keep their sight

Trials of an experimental drug which helps slow down the loss of vision caused by diabetes have had very optimistic results.

12 Jun 2006

Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration

Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults and a person's risk may partly depend upon diet.

6 Jun 2006

New MIT designed device allows visually challenged to access Internet

An MIT poet has developed a small, relatively inexpensive "seeing machine" that can allow people who are blind, or visually challenged like her, to access the Internet, view the face of a friend, "previsit" unfamiliar buildings and more.

1 Jun 2006

Bladeless LASIK as good as standard microkeratome LASIK

A Mayo Clinic study comparing femtosecond (bladeless) and mechanical microkeratome LASIK surgeries has found equal results from both types six months post-surgery, using a variety of vision and eye health measurements.

3 May 2006

Extensive study of natalizumab

Scientists have completed an extensive study of more than 3,000 patients who received a promising anti-inflammatory drug, natalizumab, that was linked to three cases of a serious brain infection in large clinical trials halted in early 2005.

7 Mar 2006

Researcher identifies key to macular degeneration progression

Dr. Jayakrishna Ambati UK HealthCare physician and Associate Professor and Vice Chair of the Department of Ophthalmology and Visual Sciences, announced a discovery by his research team that will impact how physicians and patients approach treatment for macular degeneration.

7 Feb 2006

Retinal degeneration - researchers advance understanding

Researchers have labored for decades to understand blindness-inducing neurodegenerative diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP).

18 Jan 2006

Lazy eye might see bright future

Amblyopia, commonly known as lazy eye, is a developmental disorder of spatial vision in the absence of any detectable structural or pathologic abnormalities that cannot be corrected by refractive means. Prevalence estimates range from 1% to 5% depending on the population studied and the definition used.

10 Jan 2006

Study of 30-day extended wear contact lenses

A team of researchers led by the Johns Hopkins Wilmer Eye Institute have determined that the corneal infection rate associated with the use of 30-day -extended-wear contact lenses made from silicone hydrogel is comparable to that previously reported for older lens types worn for fewer consecutive 24-hour periods.

5 Dec 2005